Adialante
Adialante is a medical imaging startup redesigning MRI from the ground up with new physics, algorithms, and hardware to make cancer screening accessible and affordable. Rather than selling multi-million-dollar equipment, Adialante deploys compact, mobile, diagnostic-grade MRI units to clinics on a flat per-scan fee, letting clinics collect insurance reimbursement and keep the margin. Its full-body scanner is roughly 80% lighter and uses about 60% less power than a traditional MRI. The company is starting with pre-biopsy prostate imaging for urology practices, with breast, orthopedic, brain, and whole-body screening on the roadmap. Founded in 2023 and part of Y Combinator's Spring 2026 batch, Adialante is backed by more than $3M in grants including NSF SBIR Phase II funding.
Adialante is profiled on the APIs.io network. Tagged areas include Company, Medical Imaging, MRI, Cancer Screening, and Healthcare.
Kin Score
Resources
Company 3
The organization behind the API